
CEL-SCI Corporation
CVMHealthcare|Biotechnology|US
$1.45
+0.08 (+5.84%)
DCF Value
$0.21
Tangible Book / Share
$0.90
Cash / Share
$0.54
Next Earnings Report
Dec 23, 2026
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jun 15, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year Survival
Oct 26, 2026 · Business Wire
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
Sep 15, 2026 · Business Wire
CEL-SCI Reports Fiscal Third Quarter 2026 Results
Aug 17, 2026 · Business Wire
SEC Filings (54)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Sep 3, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Aug 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 2, 2026 | ARS | Annual report to holders | DocumentIndex |
| Jul 2, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 15, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 27, 2026 | RW | DocumentIndex | |
| May 19, 2026 | RW | DocumentIndex | |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| May 11, 2026 | EFFECT | DocumentIndex | |
| May 1, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Apr 24, 2026 | DEL AM | DocumentIndex | |
| Apr 17, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Feb 17, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Dec 29, 2025 | 10-K | Annual report | DocumentIndex |
| Dec 3, 2025 | EFFECT | DocumentIndex | |
| Nov 24, 2025 | 8-K | Material event | DocumentIndex |
| Nov 7, 2025 | S-3 | Shelf registration | DocumentIndex |
| Nov 5, 2025 | 8-K | Material event | DocumentIndex |
| Aug 29, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 29, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 28, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 27, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 25, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2025 | EFFECT | DocumentIndex | |
| Aug 5, 2025 | S-3/A | Shelf registration | DocumentIndex |
| Jul 14, 2025 | 8-K | Material event | DocumentIndex |
| Jul 14, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Jul 3, 2025 | S-3 | Shelf registration | DocumentIndex |
| May 23, 2025 | 8-K | Material event | DocumentIndex |
| May 22, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| May 21, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| May 19, 2025 | 8-K | Material event | DocumentIndex |
| May 14, 2025 | 10-Q | Quarterly report | DocumentIndex |